Release Date: 01/11/11 08:25 Summary: September Quarter Activities Report Price Sensitive: Yes Download Document 816.52KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%